CD1B and metabolic syndrome: Given that both group 1 and group 2 CD1 molecules are expressed by antigen-presenting cells and are upregulated in multiple autoimmune conditions, it will be important to further characterize the role that antigen-presenting cells play in autoimmunity and dyslipidemia in driving CD1-restricted T cell pathology.